Literature DB >> 11692088

Levalbuterol and racemic albuterol: are there therapeutic differences?

R Ahrens, M Weinberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11692088     DOI： 10.1067/mai.2001.119407

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  Managing outpatient asthma exacerbations.

Authors:  Sitesh R Roy; Henry Milgrom
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

2.  Effects of albuterol isomers on the contraction and Ca2+ signaling of small airways in mouse lung slices.

Authors:  Philippe Delmotte; Michael J Sanderson
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-06       Impact factor: 6.914

3.  Levalbuterol versus albuterol.

Authors:  Bill T Ameredes; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

Review 4.  Levalbuterol for asthma: a better treatment?

Authors:  H William Kelly
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

5.  Albuterol enantiomer levels, lung function and QTc interval in patients with acute severe asthma and COPD in the emergency department.

Authors:  Kwang Choon Yee; Glenn A Jacobson; Richard Wood-Baker; E Haydn Walters
Journal:  Int J Emerg Med       Date:  2011-06-15

Review 6.  6. Asthma.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

Review 7.  Single-isomer levalbuterol: a review of the acute data.

Authors:  Richard Nowak
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

Review 8.  Managing outpatient asthma exacerbations.

Authors:  Sitesh R Roy; Henry Milgrom
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.